DE69719063D1 - Zusammensetzungen und verfahren zur anregung des wachstums von neuriten unter verwendung einer kombination von verbindungen mit affinität für fkbp12 und neurotrophen faktoren - Google Patents

Zusammensetzungen und verfahren zur anregung des wachstums von neuriten unter verwendung einer kombination von verbindungen mit affinität für fkbp12 und neurotrophen faktoren

Info

Publication number
DE69719063D1
DE69719063D1 DE69719063T DE69719063T DE69719063D1 DE 69719063 D1 DE69719063 D1 DE 69719063D1 DE 69719063 T DE69719063 T DE 69719063T DE 69719063 T DE69719063 T DE 69719063T DE 69719063 D1 DE69719063 D1 DE 69719063D1
Authority
DE
Germany
Prior art keywords
fkbp12
neurites
exciting
affinity
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69719063T
Other languages
English (en)
Other versions
DE69719063T2 (de
Inventor
Robert E Zelle
Michael Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vertex Pharmaceuticals Inc
Original Assignee
Vertex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25009490&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69719063(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vertex Pharmaceuticals Inc filed Critical Vertex Pharmaceuticals Inc
Publication of DE69719063D1 publication Critical patent/DE69719063D1/de
Application granted granted Critical
Publication of DE69719063T2 publication Critical patent/DE69719063T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69719063T 1996-11-13 1997-11-13 Zusammensetzungen und verfahren zur anregung des wachstums von neuriten unter verwendung einer kombination von verbindungen mit affinität für fkbp12 und neurotrophen faktoren Expired - Lifetime DE69719063T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/748,448 US5811434A (en) 1996-11-13 1996-11-13 Methods and compositions for stimulating neurite growth
PCT/US1997/020867 WO1998020892A1 (en) 1996-11-13 1997-11-13 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors

Publications (2)

Publication Number Publication Date
DE69719063D1 true DE69719063D1 (de) 2003-03-20
DE69719063T2 DE69719063T2 (de) 2003-07-31

Family

ID=25009490

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69719063T Expired - Lifetime DE69719063T2 (de) 1996-11-13 1997-11-13 Zusammensetzungen und verfahren zur anregung des wachstums von neuriten unter verwendung einer kombination von verbindungen mit affinität für fkbp12 und neurotrophen faktoren

Country Status (21)

Country Link
US (1) US5811434A (de)
EP (1) EP0941112B1 (de)
JP (1) JP2001503777A (de)
KR (1) KR20000068963A (de)
CN (1) CN1239435A (de)
AR (1) AR013873A1 (de)
AT (1) ATE232395T1 (de)
AU (1) AU5439698A (de)
BR (1) BR9712947A (de)
CA (1) CA2270629A1 (de)
CO (1) CO4920219A1 (de)
DE (1) DE69719063T2 (de)
DK (1) DK0941112T3 (de)
EA (1) EA199900462A1 (de)
ES (1) ES2187832T3 (de)
IL (1) IL129556A0 (de)
IN (1) IN183279B (de)
NZ (1) NZ335395A (de)
PL (1) PL333242A1 (de)
WO (1) WO1998020892A1 (de)
ZA (1) ZA9710258B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030036654A1 (en) * 1994-08-18 2003-02-20 Holt Dennis A. Synthetic multimerizing agents
US6150527A (en) * 1994-08-18 2000-11-21 Ariad Pharmaceuticals, Inc. Synthetic multimerizing agents
US6133456A (en) * 1994-08-18 2000-10-17 Ariad Gene Therapeutics, Inc. Synthetic multimerizing agents
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5840736A (en) * 1996-11-13 1998-11-24 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US6242468B1 (en) 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
US6514686B2 (en) 1997-04-28 2003-02-04 The University Of British Columbia Method and composition for modulating amyloidosis
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US6852496B1 (en) 1997-08-12 2005-02-08 Oregon Health And Science University Methods of screening for agents that promote nerve cell growth
US5968921A (en) 1997-10-24 1999-10-19 Orgegon Health Sciences University Compositions and methods for promoting nerve regeneration
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
AU1708099A (en) 1998-06-03 1999-12-20 Amgen, Inc. N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
GEP20043368B (en) 1998-07-17 2004-04-13 Agouron Pharma Compounds, Compositions, and Methods For Stimulating Neuronal Growth and Elongation
GB9815880D0 (en) 1998-07-21 1998-09-16 Pfizer Ltd Heterocycles
US6395758B1 (en) 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US6218423B1 (en) 1998-08-14 2001-04-17 Gpi Nil Holdings, Inc. Pyrrolidine derivatives for vision and memory disorders
US6399648B1 (en) * 1998-08-14 2002-06-04 Gpi Nil Holdings, Inc. N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6228872B1 (en) 1998-11-12 2001-05-08 Bristol-Myers Squibb Company Neurotrophic diamide and carbamate agents
AU6073300A (en) * 1999-07-06 2001-01-22 Vertex Pharmaceuticals Incorporated N-heterocyclic derivatives with neuronal activity
AU5606400A (en) * 1999-07-09 2001-01-30 Ortho-Mcneil Pharmaceutical, Inc. Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods
US6734211B1 (en) 1999-07-09 2004-05-11 Oregon Health & Sciences University Compositions and methods for promoting nerve regeneration
EP1214293A1 (de) 1999-09-08 2002-06-19 Guilford Pharmaceuticals Inc. Nicht-peptidische cyclophilin bindende verbindungen und ihre verwendung
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
AU784347B2 (en) * 1999-11-12 2006-03-16 Alcon Inc. Neurophilin ligands for treating ocular conditions
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6818643B1 (en) 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
AU1464101A (en) 1999-12-21 2001-07-03 Gpi Nil Holdings, Inc. Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
HUP0301391A3 (en) * 2000-02-11 2010-03-29 Vertex Pharma Piperazine and piperidine derivatives pharmaceutical compositions containing them and their use
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) * 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6656971B2 (en) 2001-01-25 2003-12-02 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
US20030203890A1 (en) * 2001-05-29 2003-10-30 Steiner Joseph P. Method for treating nerve injury caused as a result of surgery
WO2003062773A1 (en) * 2002-01-24 2003-07-31 Pei Electronics, Inc. Compact integrated infrared scene projector
KR20040011237A (ko) * 2002-07-29 2004-02-05 김윤희 Ｐｄｇｆ, 그의 유도체 및 약학적으로 허용되는 그의 염을함유하는 신경세포 보호 및 재생용 조성물
US20040034019A1 (en) * 2002-08-08 2004-02-19 Ronald Tomlinson Piperazine and piperidine derivatives
KR20050047132A (ko) * 2002-10-03 2005-05-19 버텍스 파마슈티칼스 인코포레이티드 신경계 질환 치료용 피페라진 및 피페리딘 유도체

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192773A (en) * 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
IL115685A (en) * 1994-11-16 2000-08-31 Vertex Pharma Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
US5543423A (en) * 1994-11-16 1996-08-06 Vertex Pharmaceuticals, Incorporated Amino acid derivatives with improved multi-drug resistance activity
US5726184A (en) * 1995-05-19 1998-03-10 Vertex Pharmaceuticals Incorporated Tetralin compounds with improved MDR activity
US5696135A (en) * 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5614547A (en) * 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US6037370A (en) * 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5801197A (en) * 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors

Also Published As

Publication number Publication date
AR013873A1 (es) 2001-01-31
CO4920219A1 (es) 2000-05-29
CN1239435A (zh) 1999-12-22
AU5439698A (en) 1998-06-03
BR9712947A (pt) 2000-03-28
WO1998020892A1 (en) 1998-05-22
NZ335395A (en) 1999-07-29
DE69719063T2 (de) 2003-07-31
ES2187832T3 (es) 2003-06-16
EP0941112A1 (de) 1999-09-15
DK0941112T3 (da) 2003-05-19
IL129556A0 (en) 2000-02-29
IN183279B (de) 1999-10-30
KR20000068963A (ko) 2000-11-25
EA199900462A1 (ru) 2000-02-28
EP0941112B1 (de) 2003-02-12
CA2270629A1 (en) 1998-05-22
ZA9710258B (en) 1998-05-28
US5811434A (en) 1998-09-22
PL333242A1 (en) 1999-11-22
JP2001503777A (ja) 2001-03-21
ATE232395T1 (de) 2003-02-15

Similar Documents

Publication Publication Date Title
DE69719063D1 (de) Zusammensetzungen und verfahren zur anregung des wachstums von neuriten unter verwendung einer kombination von verbindungen mit affinität für fkbp12 und neurotrophen faktoren
DE69725169D1 (de) Zusammensetzungen und verfahren zur anregung des wachstums von neuriten
DE69224463D1 (de) Neues Metallocen und Verfahren zur Herstellung von Polyolefinen unter Verwendung desselben
DE3776302D1 (de) Verfahren zur feststellung von gasen unter anwendung von chemisorption und physisorption.
DE69927022D1 (de) Verfahren zur steuerung der benutzung von softwarekomponenten
DE69420547D1 (de) Wellenform-mischungsverfahren für system zur text-zu-sprache umsetzung
DE69726539D1 (de) Schaumglasgegenstand zur vorbereitung von oberflächen, verwendung dafür und verfahren zu dessen herstellung
DE69725488D1 (de) Verfahren zur Herstellung einer Asphaltzusammensetzung
DE69428331D1 (de) Katalytische Zusammensetzung und Verfahren zur Oxychlorierung von Ethylen unter Verwendung derselben
DE69910863D1 (de) Verfahren zur Herstellung von Calciumfluorid und Calciumfluorid für Fotolithographie
DE69933887D1 (de) Verfahren zur herstellung von triazinen unter verwendung einer kombination von lewis-säure und reaktionpromotoren
DE59509134D1 (de) Verfahren zur isomerisierung von spirozyklischen beta-aminocarboxyl- und beta-aminocarbonylverbindungen
DE69522446T2 (de) Verfahren zur cetanverbesserung von destillatfraktionen
DE69905426D1 (de) Verfahren zur Herstellung von Kohlenmonoxid
DE60013212D1 (de) Verfahren zur Konzentrationsregelung einer Gasmischung
DE69920967D1 (de) Verfahren zur cvd unter verwendung von bi-alkoxiden
DE69312528D1 (de) Verfahren zur Herstellung von Fibrinogen-Rezeptor-Antagonisten
DE69421359D1 (de) Verfahren zur Trennung von Stickstoff und Kohlendioxid unter Verwendung von keramischen Materialien
DE69811505D1 (de) Verfahren und zusammensetzungen zur bekämpfung von biologischer verschmutzung unter verwendung von sulfaminsäuren
DE69714894D1 (de) Reagenz und Verfahren zur Regulierung der Zusammensetzung einer Gasmischung
DE69801490T2 (de) Verfahren zur ununterbrochener herstellung einer wässrigen mischung von (e)-caprolactam und (e)-caprolactamvorläufern
DE69811533D1 (de) Verfahren zur vermehrung der produktion und zur verbesserung der qualität von sperma
DE69823174D1 (de) Verfahren zur cvd bei niedrigen temperaturen unter verwendung von bi-carboxylaten
DE69811820D1 (de) Verfahren zur Isomerisierung von C8-Aromaten unter Verwendung einer Recyclierung
DE60030396D1 (de) Anordnung und Verfahren zur Reduzierung der Sprachübertragungszeit und zur Verbesserung der Sprachqualität unter Verwendung von Halbsprachblöcken

Legal Events

Date Code Title Description
8364 No opposition during term of opposition